Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Clinical Cardiology

Volumn 39, Issue 2, 2016, Pages 103-110

  O'Neal, Wesley T ^a   Efird, Jimmy T ^b   Judd, Suzanne E ^c   McClure, Leslie A ^d   Howard, Virginia J ^d   Howard, George ^c   Soliman, Elsayed Z ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c DREXEL UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; WARFARIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATRIAL FIBRILLATION; AWARENESS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GEOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; RISK ASSESSMENT; SELF REPORT; THROMBOEMBOLISM; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; ETHNOLOGY; HEALTH DISPARITY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STROKE; TIME FACTOR; UNITED STATES;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; AWARENESS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 84959489783     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22501     Document Type: Article

References (25)

1. Go AS, Hylek EM, Phillips KA, et al., Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370-2375.
2. Benjamin EJ, Levy D, Vaziri SM, et al., Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994; 271: 840-844.
3. Heeringa J, Kors JA, Hofman A, et al., Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008; 156: 1163-1169.
4. Wolf PA, Abbott RD, Kannel WB,. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22: 983-988.
5. Gottdiener JS, Arnold AM, Aurigemma GP, et al., Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000; 35: 1628-1637.
6. Soliman EZ, Safford MM, Muntner P, et al., Atrial fibrillation and the risk of myocardial infarction [published correction appears in JAMA Intern Med. 2014;174:308]. JAMA Intern Med. 2014; 174: 107-114.
7. Krahn AD, Manfreda J, Tate RB, et al., The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476-484.
8. Benjamin EJ, Wolf PA, D'Agostino RB, et al., Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98: 946-952.
9. Stewart S, Hart CL, Hole DJ, et al., A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113: 359-364.
10. Conen D, Chae CU, Glynn RJ, et al., Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011; 305: 2080-2087.
11. Chamberlain AM, Gersh BJ, Alonso A, et al., Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med. 2015; 128: 260. e1-267.e1.
12. Schnabel RB, Yin X, Gona P, et al., 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015; 386: 154-162.
13. Howard VJ, Cushman M, Pulley L, et al., The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005; 25: 135-143.
14. Soliman EZ, Howard G, Meschia JF, et al., Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011; 42: 2950-2953.
15. Sokolow M, Lyon TP,. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949; 37: 161-186.
16. Gage BF, Waterman AD, Shannon W, et al., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285: 2864-2870.
17. Gray RJ, Tsiatis AA,. A linear rank test for use when the main interest is in differences in cure rates. Biometrics. 1989; 45: 899-904.
18. Piccini JP, Sinner MF, Greiner MA, et al., Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation. 2012; 126: 2200-2207.
19. O'Neal WT, Sangal K, Zhang ZM, et al., Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol. 2014; 37: 750-755.
20. Efird JT, O'Neal WT, Kennedy WL, et al., Grand challenge: understanding survival paradoxes in epidemiology. Front Public Health. 2013; 1: 3.
21. Corley SD, Epstein AE, DiMarco JP, et al,; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004; 109: 1509-1513.
22. Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146: 857-867.
23. Odden MC, Coxson PG, Moran A, et al., The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011; 124: 827. e5-833.e5.
24. Stafford RS, Robson DC, Misra B, et al., Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996. Arch Intern Med. 1998; 158: 2144-2148.
25. Fang MC, Stafford RS, Ruskin JN, et al., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004; 164: 55-60.